Windtree Therapeutics Announces Presentation of Preclinical Data on Istaroxime and a Selective SERCA2a Activator at the European Society of Cardiology Heart Failure Conference May 17, 2025 — Neutral
WINT GlobeNewsWire — May 12, 2025ePoster presentation advances the preclinical evaluation of the importance of SERCA2a function to reduce arrythmias with istaroxime and a selective SERCA2a activator in the setting of ischemia and reperfusion ePoster presentation advances the preclinical evaluation of the importance of SERCA2a function to reduce arrythmias with istaroxime and a selective SERCA2a activator in the setting of ischemia and reperfusion

nuVizz and Ford Motor Company to Share Keys to 96% Parts Delivery Success at Home Delivery World — Neutral
F GlobeNewsWire — May 12, 2025ATLANTA, May 12, 2025 (GLOBE NEWSWIRE) -- nuVizz , a leading innovator in last-mile transportation management solutions (TMS), will present alongside Ford Motor Company at Home Delivery World 2025, one of North America's premier logistics and supply chain conferences. This session will provide a behind-the-scenes look at how nuVizz's specialized last-mile TMS is streamlining one of the most expensive aspects of Ford's logistics operations, creating a more innovative and efficient Dealer Delivery Service (DDS) network for parts deliveries.

CPS Technologies to Participate in Sidoti Microcap Virtual Conference — Neutral
CPSH GlobeNewsWire — May 12, 2025NORTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- CPS Technologies Corporation (NASDAQ:CPSH) (“CPS” or the “Company”) today announced that, as it did last year, the Company will participate in the Sidoti Microcap Virtual Conference on May 21 and 22, 2025. A general presentation by management will be held at 9:15 a.m. Eastern on May 21, with one-on-one calls scheduled throughout the 21st and 22nd; institutional investors are encouraged to contact Sidoti directly or CPS investor relations with any questions or to confirm a time to speak with management. The general presentation will be webcast and will subsequently be made available …

eBay's AI tools streamline seller listings and enhance buyer searches, boosting efficiency and increasing inventory visibility, which can drive higher sales. EBAY's low capital expenditures and high free cash flow allow for share buybacks, dividend increases, and technology acquisitions, making it financially robust. The Company's valuation is attractive compared to Amazon, with a lower P/E ratio and significant share buybacks, suggesting it is undervalued.

DeFi Development Corp. Purchases Record 172,670 SOL, Surpasses $100M in Treasury Holdings — Neutral
DFDV JNVR GlobeNewsWire — May 12, 2025BOCA RATON, FL, May 12, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) announced today the purchase of 172,670 Solana (“SOL”) at an average purchase price of $136.81 and valued at approximately $23.6 million. This marks the Company's 10th Solana purchase under its digital asset treasury strategy and the largest purchase to date. Following the transaction, DeFi Development Corp. now holds a total of 595,988 SOL, valued at approximately $102.7 million, inclusive of staking rewards.

Annexon Reports First Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones — Neutral
ANNX GlobeNewsWire — May 12, 2025FDA Meeting for Tanruprubart (formerly ANX005), the First Potential Targeted Therapy for GBS, Scheduled for Second Quarter 2025 Ahead of Planned BLA Submission

Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis — Neutral
QNTM GlobeNewsWire — May 12, 2025TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced that dosing of drug has completed in 90-day oral toxicity and toxicokinetic studies for Lucid-21-302 (Lucid-MS) for Multiple Sclerosis (“MS”). These studies were commissioned to provide data to support an IND application with the US FDA.

CervoMed Reports First Quarter 2025 Financial Results and Provides Corporate Updates — Neutral
CRVO GlobeNewsWire — May 12, 2025Reported positive 16-week results from the extension phase of the Phase 2b RewinD-LB trial, demonstrating proof-of-concept for neflamapimod as a potential treatment for dementia with Lewy bodies (DLB)

Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation — Neutral
TVGN GlobeNewsWire — May 12, 2025WARREN, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN). As the biopharma industry faces increasing competition from international markets and an evolving regulatory landscape, Tevogen Bio's innovative business model positions it as a potential leader in the shift towards cost-efficient, value-driven healthcare.

Amber International Unveils US$100M Crypto Ecosystem Reserve to Expand Institutional Crypto Adoption — Neutral
AMBR DFDV PRNewsWire — May 12, 2025Unlocking the potential of digital assets for institutions and fueling Amber International's strategic expansion SINGAPORE , May 12, 2025 /PRNewswire/ -- Amber International Holding Limited (Nasdaq: AMBR) ("Amber International", "AMBR", "we", "us", or the "Company"), a leading provider of institutional crypto financial services and operating under the brand name "Amber Premium", today announced the launch of its upsized crypto ecosystem reserve plan of US$100 million. The strategic treasury reserve initiative is designed to accelerate the Company's expansion and cement its leadership at the intersection of traditional and decentralized finance.

TEL AVIV, Israel , May 12, 2025 /PRNewswire/ -- Arbe Robotics Ltd. (Nasdaq: ARBE) (TASE: ARBE), a global leader in perception radar solutions, today announced that Kobi Marenko, Chief Executive Officer will participate in the following investor conferences: Ladenburg Innovation Expo Format: In-person presentation and meetings When: Wednesday, May 21, presentation at 2:00 pm ET Where: New York City 15th Annual Roth London Conference Format: In-person meetings When: Wednesday, June 25 Where: London, U.K. The Ladenburg Innovation Expo presentation will be webcast from Arbe's Investor Relations website: https://ir.arberobotics.com/news/ir-calendar.

Brenmiller Energy and New York Power Authority Showcase Thermal Energy Storage Success at SUNY Purchase College — Neutral
BNRG Accesswire — May 12, 2025Innovative pilot project highlights the role of thermal energy storage in decarbonizing public institutions Pilot installations offer replicable frameworks for wider adoption Brenmiller's bGen™ intended to reduce 550 metric tons of CO2 emissions annually The project and its key findings will be presented in a webinar on May 19, 2025 hosted by the Renewable Thermal Collaborative TEL AVIV, IL / ACCESS Newswire / May 12, 2025 / Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy" or the "Company") (Nasdaq:BNRG), a leading global provider of thermal energy storage ("TES") solutions for industrial and utility customers, announced today the publication of a joint case …

Ensysce Biosciences Bolsters Management Team with Regulatory Expert — Neutral
ENSC Accesswire — May 12, 2025~ Advanced Preparation for New Drug Application ~ SAN DIEGO, CA / ACCESS Newswire / May 12, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for abuse and overdose, today announced it has added Tracy Hysong, CCRA as Senior Director of Regulatory Affairs to its management team. Ms. Hysong is a Certified Clinical Research Associate (CCRA) through the Association of Clinical Research Professionals with years of experience undertaking regulatory activity at the University of California Davis (UC Davis).

Vaxart Addresses Frequently Asked Questions on Reverse Stock Split Proposal in Definitive Proxy Statement — Neutral
VXRT GlobeNewsWire — May 12, 2025Company Urges Stockholders to Vote FOR Reverse Stock Split Proposal at Upcoming Annual Meeting to Avoid Nasdaq Delisting SOUTH SAN FRANCISCO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today addresses frequently asked stockholder questions regarding a reverse stock split proposal at the Company's Annual Meeting taking place on Wednesday, May 21, 2025, to regain Nasdaq compliance.

Keros Therapeutics Announces Participation at Bank of America 2025 Global Healthcare Conference — Neutral
KROS GlobeNewsWire — May 12, 2025LEXINGTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (“TGF-ß”) family of proteins, today announced that Keros' Chair and Chief Executive Officer Jasbir S.

MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights — Neutral
MBX GlobeNewsWire — May 12, 2025Topline results for the Phase 2 Avail™ evaluating canvuparatide in patients with hypoparathyroidism expected in 3Q 2025 Investigational New Drug submission for MBX 4291 on track for 2Q 2025 $240.8 million in cash, cash equivalents and marketable securities as of March 31, 2025; expected to support operations into mid-2027 CARMEL, Ind., May 12, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today reported financial results for the first quarter ended March 31, 2025, and highlighted recent …

Conagra Brands Brings Diverse Collection of Snacks to 2025 Sweets & Snacks Expo — Neutral
CAG PRNewsWire — May 12, 2025Meat Snacks and Sweet & Salty Offerings Highlight Two Booths in Indianapolis CHICAGO , May 12, 2025 /PRNewswire/ -- Conagra Brands, Inc. (NYSE: CAG), one of North America's leading branded food companies, is preparing to showcase the company's dynamic range of snacks at the National Confectioners Association's 2025 Sweets & Snacks Expo in Indianapolis. Meat snacks, sweet treats, and salty snacks comprise the company's $3.2 billion 1 snacks portfolio, with numerous industry-leading brands headlining Conagra Brands' Expo presence.

Ramaco Hires Executive Vice President for Critical Mineral Operations to Lead the Brook Mine Rare Earth Element and Critical Minerals Project — Neutral
METC METCB PRNewsWire — May 12, 2025SHERIDAN, Wyo. , May 12, 2025 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB) announced today it has hired Michael Woloschuk, an internationally recognized leader in the critical minerals industry, with over 30 years of project development experience in all parts of the world.

FOX REPORTS THIRD QUARTER FISCAL 2025 REVENUES OF $4.37 BILLION, NET INCOME OF $354 MILLION, AND ADJUSTED EBITDA OF $856 MILLION — Neutral
FOX FOXA PRNewsWire — May 12, 2025NEW YORK , May 12, 2025 /PRNewswire/ -- Fox Corporation (Nasdaq: FOXA, FOX; "FOX" or the "Company") today reported financial results for the three months ended March 31, 2025. The Company reported total quarterly revenues of $4.37 billion, an increase of $924 million or 27% from the amount reported in the prior year quarter.

Jack Henry & Associates Announces Regular Quarterly Dividend — Neutral
JKHY PRNewsWire — May 12, 2025MONETT, Mo. , May 12, 2025 /PRNewswire/ -- Jack Henry & Associates, Inc. (NASDAQ: JKHY) today announced its Board of Directors declared a regular quarterly cash dividend of $.58 per share.
